Lorzone

Quick links to important sections

Lorzone

Method of action: Miorelaxant

Treatment option:

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Lorzone

Property Description
Active Ingredient Chlorzoxazone
Form Oral Capsule (Immediate-release formulation)
Pharmacological Class Centrally Acting Skeletal Muscle Relaxant (CAMR)
General Purpose Relief of acute musculoskeletal discomfort and spasm
Origin Synthetic Benzoxazole Derivative

Defining the Medicine and Its Class

Lorzone is a specific, single-ingredient, prescription preparation containing the active chemical entity Chlorzoxazone, which is structurally defined as a synthetic benzoxazole derivative. It is classified as a Centrally Acting Skeletal Muscle Relaxant (CAMR), a class of drugs clinically recognized for modulating nervous system activity to achieve muscle relaxation. Unlike certain other muscle relaxants, Chlorzoxazone’s effect is systemic and is confirmed by pharmacological studies to occur primarily within the central nervous system (CNS), affecting the spinal cord and subcortical areas of the brain. The medication is presented as an oral capsule, ensuring its systemic effect across the body.


Composition, Form, and General Purpose

The active component, Chlorzoxazone, is formulated into this oral capsule preparation. Lorzone is designated for use as an adjunctive measure—meaning it complements other therapies like rest and physical therapy—to relieve the discomfort associated with painful, involuntary muscle spasm stemming from acute musculoskeletal conditions. The drug's general mechanism involves inhibiting the excessive nerve signals, known as multisynaptic reflex arcs, that drive muscle rigidity. By modulating this neurological hyperactivity, the general benefit of Lorzone is the targeted reduction of muscle tightness, which eases pain and contributes to increased mobility during the acute phase of discomfort.

Regulatory References

  1. NIH LiverTox: Chlorzoxazone

What side effects are possible with Lorzone?

Possible Side Effects and Safety Information

The official regulatory safety profile for Lorzone (chlorzoxazone) distinguishes between effects that are noted by an occasional patient and rare, serious adverse reactions, primarily classifying effects by the body system affected.

Frequently Noted Effects

The most frequent adverse reactions noted in official labeling are generally related to the Central Nervous System (CNS). These effects are classified as noted by an occasional patient and include:

  • Drowsiness
  • Dizziness
  • Lightheadedness
  • Malaise (general feeling of being unwell)
  • Over-stimulation

Other less common gastrointestinal disturbances, such as nausea or diarrhea, may also be noted.

Serious and Rare Adverse Reactions

Regulatory documentation highlights certain rare, clinically significant adverse reactions. The most critical safety concern is the rare, unpredictable development of Hepatocellular Toxicity (liver damage), which has been reported in rare instances and can be severe. Accordingly, the medicine is contraindicated in individuals with active hepatic disease.

Other serious reactions classified as rare or extremely rare include:

  • Allergic-type skin reactions (e.g., rashes, petechiae, ecchymoses)
  • Gastrointestinal bleeding
  • Severe hypersensitivity reactions (Angioneurotic edema, Anaphylactic reactions)

Safety Considerations and Constraints

The safety profile includes specific constraints regarding use in special populations. Safe use of chlorzoxazone has not been established in pregnant women or in the pediatric population. Concomitant use with alcohol or other CNS depressants may lead to an additive effect, intensifying CNS-related adverse reactions.

An administration-related note states that a harmless reddish-orange or purple-red urine discoloration may occur due to a metabolite, a finding of no known clinical significance.

Overdose and Emergency Response

Overdose and When to Seek Help

The official regulatory documentation for Chlorzoxazone (Lorzone) overdose describes specific clinical manifestations and mandates immediate emergency action. Overdose may initially present with symptoms of central nervous system (CNS) depression, including profound drowsiness, dizziness, lightheadedness, and general malaise. Gastrointestinal distress, such as nausea, vomiting, and diarrhea, are also documented early findings.

A significant musculoskeletal manifestation is a marked loss of muscle tone, which may render voluntary movement difficult or impossible, often accompanied by decreased or absent deep tendon reflexes. The most serious, regulator-stated risks include the potential for respiratory depression and irregular breathing, and a notable drop in blood pressure (hypotension).

Mandatory Emergency Action

The official prescribing information requires that individuals seek immediate emergency medical attention upon the suspicion or manifestation of any symptom of overdose. This is essential due to the risk of severe respiratory or cardiovascular compromise.

Supportive Management

There is no specific pharmacologic antidote for Chlorzoxazone overdose; furthermore, the use of cholinergic or analeptic drugs is explicitly advised against in the official instructions. Management is entirely supportive, focusing on initial decontamination procedures (such as gastric lavage and activated charcoal), ensuring a patent airway, providing respiratory support (oxygen, artificial respiration), and using appropriate measures, like vasopressor agents, to manage severe hypotension.

Therapeutic Uses of Lorzone

Lorzone is commonly used as an adjunct to rest, physical therapy, and other measures for the management of discomfort associated with acute, painful musculoskeletal conditions.

This medication is relevant in conditions characterized by periods of heightened symptoms, such as muscle strains, muscle sprains, and acute low back pain where muscle hyperactivity is a factor. It is applied across domains where additional symptomatic support is needed, and is relevant for easing the symptoms of intense involuntary muscle spasm and musculoskeletal rigidity that can arise from acute injury.

The supportive relief provided by Lorzone helps address symptom clusters that may become disruptive, contributing to improved patient comfort and assisting with maintaining functional stability during the temporary, challenging phase of injury recovery. As it supports patients during difficult episodes of heightened discomfort, it may be part of symptomatic management alongside non-pharmacological measures, which contributes to improved day-to-day comfort during symptomatic periods.


Quick Fact: Used to help ease Involuntary Muscle Spasm

Regulatory References

  1. NIH DailyMed database

Eligibility and Restrictions for Use

Official Eligibility and Population Restrictions

Lorzone (chlorzoxazone) is strictly classified by regulatory authorities based on a patient's population group and existing health status. The primary authorized user population consists of adults who do not meet any official exclusion criteria.

Population Group Eligibility Status
Contraindicated Prohibited for patients with a known intolerance or hypersensitivity to chlorzoxazone or any of the formulation's components.
Hepatic Health Status Use must be discontinued immediately if symptoms suggestive of liver dysfunction (hepatotoxicity) occur. Use in patients with existing liver concerns requires caution.
Pediatric Patients Safety and effectiveness have not been established in this population, classifying its use as not authorized for children.
Older Adults Use requires caution due to potential increased sensitivity to the drug and risk of adverse reactions.

Conditional Use Status

The official labeling defines conditional eligibility for women of childbearing potential. The safe use of Lorzone in pregnancy has not been established with respect to fetal development. Use in this population requires that the potential benefit justify the possible risk. Likewise, caution must be exercised when administering to nursing women, as it is not known whether the active ingredient is excreted into human milk.

What should I know about interactions with other medicines?

Lorzone Interactions with other medicines and products

Lorzone (chlorzoxazone) is a Centrally Acting Skeletal Muscle Relaxant, and its interaction profile centers on two main areas: reinforcing effects on the nervous system and specific metabolic alterations.

Documented Pharmacodynamic Interactions

The concomitant use of alcohol or other Central Nervous System (CNS) depressants may result in an additive effect. These CNS depressants include, but are not limited to, other muscle relaxants, opioid analgesics, certain antihistamines, and medications used for anxiety or sleep. This additive effect is formally recognized in the prescribing information as a significant interaction-related constraint.

Pharmacokinetic and Metabolic Interactions

Lorzone is primarily cleared from the body through metabolism by the liver enzyme CYP2E1. This metabolic pathway forms the basis for two specific interaction notes:

  • Exposure Modification of Other Drugs: Chlorzoxazone co-administration is documented to increase the systemic exposure, specifically the Area Under the Curve (AUC), of the CYP3A substrate Midazolam.
  • Interactions with Food/Herbal Products: Ingestion of Watercress has been reported to increase the plasma exposure of Lorzone by affecting its CYP2E1 metabolism. Similarly, co-use with the herbal product St John's Wort is cited in caution listings due to the risk of enhanced CNS depressant effects.

Population-Specific Interaction Cautions

Regulatory documents advise caution for Lorzone use in patients with liver disease due to its hepatic metabolism. Additionally, use in geriatric patients requires extreme caution due to the potential for exacerbation of CNS depression.

Mechanism of Action

Influence on Central Nervous System Pathways

Lorzone (chlorzoxazone) acts as a centrally-acting muscle relaxant, exerting its primary effects at the level of the spinal cord and subcortical areas of the brain. The precise mechanism is not fully understood, but it is believed to involve influencing neurotransmitter activity, potentially including the inhibitory neurotransmitter GABA. This central action alters the transmission of nerve impulses within the central nervous system, resulting in reduced central nervous system excitability.


Impact on Polysynaptic Reflex Arc Activity

The drug primarily targets and modifies the activity of polysynaptic reflex arcs. These complex neural pathways are involved in the generation of rapid and sustained electrical discharge to skeletal muscle. By suppressing these multisynaptic sequences, Lorzone's action alters the output of overactive physiological pathways and decreases efferent nerve impulse transmission to skeletal muscle.


️ Physiological Consequences of Decreased Pathway Activity

The physiological effect of the drug's action on the central nervous system and reflex pathways is a decrease in basal muscle fiber electrical activity and passive resistance to stretch. This leads to a more regulated state within the targeted musculature, impacting the contractile state of striated muscle.

Dosage and Administration Information

How to Use Lorzone: Official Administration Guidelines

Lorzone (Chlorzoxazone) is strictly administered via the oral route as an immediate-release tablet. The official prescribing information defines the dosage, frequency, and conditions for its use as a measure supplementary to other non-pharmacological therapies.


Administration Protocol

The usage of this medication is guided by the following principles.

Instruction Detail
Route of administration: Oral administration only.
Standard Dosing Schedule (Adults): Initial and maintenance doses typically range from 250 mg to 750 mg per intake.
Frequency and Timing: Dosing is administered in a divided regimen of three or four times daily (3 to 4 times per day).
Administration Context: The tablet may be taken with food or milk if the individual experiences stomach upset.
Dose Adjustment Rule: As clinical improvement occurs, the dosage should be reduced to the minimum effective amount.
Maximum Daily Dose: The total adult dose administered in a 24-hour period should not exceed 3,000 mg (3 grams).
Course Duration: The medicine is intended for short-term use for acute conditions, as an adjunct to rest and physical therapy.

Population-Specific Use

Official documents indicate that caution is advised for older adults due to potential age-related organ changes, and starting with a lower dosage may be advisable. For pediatric patients, dosing must be determined based on body weight or body surface area, if used.


Procedural Summary

The official protocol establishes a frequent, divided-dose pattern, requiring the medication to be taken multiple times daily. This short-term use is structured as a supplementary measure to support the primary treatment plan, with an explicit rule that the amount taken must be lowered upon symptomatic improvement.

Recent Clinical Evidence

Lorzone: Recent Clinical Evidence

Clinical evidence concerning Lorzone (chlorzoxazone) examines its role as an adjunct therapy for the relief of discomfort associated with acute, painful musculoskeletal conditions. The drug is classified as a centrally acting skeletal muscle relaxant.

Studies Examining Clinical Outcomes

Research studies have evaluated the effect of chlorzoxazone primarily in the context of acute low back pain and muscle spasms. The primary focus of these trials is often short-term relief, typically over periods of one to two weeks, as evidence is limited regarding its use for chronic conditions.

Specific studies have reported the following outcomes:

Focus Area Study Finding Caveat
Pain Intensity Studies reported changes in pain intensity metrics (e.g., VAS scores) compared to baseline when used alone or in combination with other analgesics. Comparisons to other single muscle relaxants have not established clear superiority.
Combination Use Research exploring combination therapy, such as with an NSAID (Non-Steroidal Anti-Inflammatory Drug), has reported greater pain relief when compared to the NSAID used alone. These results focus on short-term management of acute pain.

Safety Data in Clinical Trials

Clinical trial design included the collection of long-term safety data. While generally associated with central nervous system side effects such as drowsiness and dizziness, rare cases of serious, idiosyncratic liver injury (hepatotoxicity) have been reported across its usage history. These reports highlight the importance of monitoring for potential signs of liver problems during treatment.

Evidence regarding the efficacy and safety of chlorzoxazone in specific patient groups, such as geriatric or pediatric populations, remains limited.

Frequently Asked Questions (FAQ)

Common questions about Lorzone (FAQ)

Q: What is the main difference between Lorzone and over-the-counter pain relievers?

Lorzone (chlorzoxazone) is classified by regulatory documents as a centrally acting skeletal muscle relaxant. This means its primary action is in the central nervous system to help reduce muscle spasms.

In contrast, over-the-counter pain relievers, such as ibuprofen, are generally non-steroidal anti-inflammatory drugs (NSAIDs) that belong to a different drug class. They work primarily to manage pain and inflammation.


Q: How quickly does Lorzone usually start working after taking it?

Official pharmacokinetic data indicates that the active ingredient is rapidly absorbed into the body. Plasma concentrations can typically be detected within the first 30 minutes.

The medication generally reaches its peak level in the blood about one to two hours after administration.


Q: How long does the effect of one dose of Lorzone typically last?

Studies related to drug metabolism suggest that the therapeutic effect of a single dose generally lasts for approximately three to four hours. This duration is related to how quickly the body processes and clears the medication.


Q: Is Lorzone an opioid, a painkiller, or something else entirely?

Lorzone is classified as a skeletal muscle relaxant used as an adjunct (supplement) to therapy for musculoskeletal discomfort. According to official classification, it is a prescription-only drug but is not categorized as a narcotic, an opioid, or a federally controlled substance.


Q: Are there any specific supplements or vitamins that should be avoided when taking Lorzone?

Official prescribing information advises patients to inform their healthcare provider about all prescription and over-the-counter medicines, vitamins, and herbal products they are taking. This step is advised because certain supplements, like St. John's Wort or Watercress, have been associated with potential drug interactions that can increase sedation or change the way the body processes the medication.


Q: Are there restrictions on driving or operating machinery while using Lorzone?

Yes. Because the medication can cause central nervous system effects such as drowsiness and dizziness, regulatory safety information explicitly warns against driving or operating hazardous machinery.

Patients are generally advised to avoid these activities until they understand how the medication affects coordination, reaction time, or judgment.


Q: Does Lorzone have a potential for dependence or addiction described in official documents?

Lorzone is not classified as a controlled substance. However, clinical safety reviews note that, similar to other centrally acting medications, extended use may increase the risk of tolerance and potential dependence.


Q: Can Lorzone be taken at the same time as cold and flu medications?

Caution is advised because Lorzone should not be combined with other drugs that cause drowsiness. This group can include specific components found in some cold and flu remedies, such as antihistamines or opioid-containing cough suppressants. Combining these can result in an additive effect that intensifies CNS depressant side effects.


Q: What are the general recommendations for food and drink intake while on Lorzone?

The official administration instructions state that the medication may be taken with food or milk. This conditional recommendation is suggested if the individual experiences stomach upset or discomfort while taking the tablets.


Q: Are there any known effects of Lorzone on blood pressure or heart rate?

Official adverse event reports indicate that a fast heartbeat has been reported as a rare side effect. Additionally, changes such as low blood pressure have been noted in clinical summaries of overdose cases. These effects are not reported as common occurrences during normal use.


Q: Are there high-level warnings about mixing Lorzone with herbal remedies?

Official prescribing documents advise caution regarding the co-use of Lorzone with herbal products. This is because some herbal supplements, such as St. John's Wort, can potentially enhance the CNS depressant effects of the medicine or interfere with how the body processes it.


Q: Can Lorzone cause issues with sleep patterns or insomnia?

Lorzone is known to frequently cause drowsiness. However, official adverse event lists also include a possible effect of 'over-stimulation' in occasional patients. While insomnia is not listed as a frequent side effect, the possibility of over-stimulation or changes to alertness may be noted.


Q: Does Lorzone cause changes in appetite or weight as a possible effect?

Official warnings note that decreased appetite or loss of appetite has been reported as a rare side effect. Loss of appetite may be noted as an early symptom associated with the rare risk of liver injury. Weight change is not specifically listed as a known effect.


Q: Is it normal to feel a bit restless or agitated sometimes while taking Lorzone?

The product label notes 'over-stimulation' as a possible central nervous system effect in occasional patients. This particular effect may manifest in individuals as feelings of agitation or restlessness.


Q: What should be done if someone experiences stomach discomfort while taking Lorzone?

According to the official administration instructions, if stomach upset or discomfort occurs, the medication may be taken with food or milk to help manage the gastrointestinal effects.


Q: Are there any common interactions between Lorzone and depression medications?

Official warnings caution against combining Lorzone with any drug that causes central nervous system (CNS) depression. This includes certain medications prescribed for anxiety, sleep, or depression. Combining them can result in an additive effect that increases side effects like drowsiness.


Q: Is Lorzone generally safe for people with diagnosed kidney problems?

Lorzone is primarily metabolized by the liver. However, clinical guidance indicates that caution is advised for individuals with serious kidney issues, as the way the body processes the medication may be affected.


Q: What is the most frequently reported side effect in patient communities?

The most frequently noted adverse reactions in official prescribing information are related to the central nervous system. These include common effects such as drowsiness, dizziness, lightheadedness, and malaise (a general feeling of being unwell).


Q: Do official prescribing documents mention any risk of withdrawal symptoms when stopping Lorzone?

Lorzone is intended for short-term use. While the official prescribing documents do not specifically focus on withdrawal, clinical safety notes indicate that abrupt discontinuation after prolonged use may be associated with withdrawal symptoms.


Q: Does the age of the patient change how Lorzone is processed by the body?

Official documents advise caution for older adults due to the potential for increased sensitivity to the drug and its CNS depressant effects. For this reason, official guidance suggests that lower starting dosages may be advisable for the geriatric population.


Q: Can someone be allergic to Lorzone even if they've never taken a muscle relaxer before?

Yes. The medication is officially contraindicated for anyone with a known intolerance or hypersensitivity specifically to chlorzoxazone or any of its components. This warning does not depend on a prior history of using other muscle relaxers.


Q: What are the signs of a possible serious allergic reaction to Lorzone?

Official patient safety information describes signs of a possible serious allergic reaction. These signs include hives, difficulty breathing, and swelling that may affect the face, lips, tongue, or throat.

How should Lorzone be stored and disposed of?

Storage and Disposal Requirements for Lorzone (Chlorzoxazone)

Official regulatory documentation requires Lorzone tablets to be stored at controlled room temperature, maintaining a temperature range of 20° to 25°C (68° to 77°F), with temporary excursions permitted between 15° and 30°C (59° and 86°F).

Container and Child Safety

The medication must be dispensed and kept in a tight container and requires a child-resistant closure to protect it from moisture. It is an explicit regulatory instruction that the product must be kept out of the reach of children at all times.

Disposal Guidance

The official prescribing information does not provide specific drug-labeled instructions for household disposal of unused or expired Lorzone. Disposal should be carried out according to local pharmaceutical waste management guidelines or general protocols.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Lorzone found in:

A-Z Index: